• Chinese Traditional and Herbal Drugs. 2025, 56(24): 9258-9268.
    Molecular systematics integrating molecular biology, taxonomy, and genomics, elucidates phylogenetic relationship, genetic diversity, and evolutionary history of species, providing essential support for the development of new medicinal resources, the origin and evolution of bioactive compounds, and the conservation and utilization of resources. The genus Schisandra. plants possess significant medicinal value, particularly in hepatoprotection, anti-inflammation, antitumor activity, and neuroprotection. Using Schisandra medicinal plants as a case study, this paper summarizes the technical support provided by molecular systematics for Chinese material medica resources in species classification and identification, genetic diversity assessment, and novel medicinal resources discovery, and highlights its key role in addressing confusion in traditional Chinese medicine caused by homonyms and synonyms. With further advances in genomics, molecular systematics is expected to play an increasingly important role in the exploration and utilization of new medicinal resources as well as in the establishment of accurate identification and evaluation systems.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9233-9245.
    Ulcerative colitis (UC) is a chronic, nonspecific inflammatory disease characterized by diffuse, continuous lesions of the colorectal mucosa. Accumulating evidence indicates that amino acids and their metabolites exhibit biological activities such as anti-inflammation, anti-oxidation, repair of intestinal barrier and regulation of immune response. These effects enable targeted intervention in the core pathological characteristics of UC. Traditional Chinese medicine (TCM) can effectively inhibit the disease progression of UC. It also alleviates complex clinical symptoms and reduces the adverse reactions and complications associated with Western therapies. Based on this, this article adopts a novel perspective of TCM regulating amino acid metabolic reprogramming to treat UC. This review systematically dissect the pharmacological mechanisms by which herbal formulas and their bioactive constituents modulate amino-acid metabolic reprogramming. It aims to furnish new therapeutic concepts and a theoretical framework for the use of TCM in managing UC, thereby accelerating its modernization and clinical translation.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9246-9257.
    Ischemic stroke is a leading cause of neurological disability, and its pathogenesis is complex, involving neuronal injury, blood-brain barrier (BBB) disruption, and inflammatory responses. In recent years, drug discovery based on natural products has attracted considerable attention. Tetramethylpyrazine (TMP), a bioactive constituent isolated from Ligusticum chuanxiong, is one of the few traditional Chinese medicine–derived compounds with demonstrated efficacy against ischemic stroke. Multiple formulations have been developed, among which TMP hydrochloride injection and TMP phosphate injection are included in China’s National Reimbursement Drug List. This review systematically summarizes the pharmacodynamic effects and mechanisms of TMP against ischemic stroke. TMP markedly attenuates ischemia-reperfusion injury and promotes the repair of damaged brain tissue. Its mechanisms of action include inhibition of neuronal injury, preservation of BBB integrity, and enhancement of neuroplasticity. Collectively, these findings provide a robust scientific foundation for the clinical application of TMP in the treatment of ischemic stroke.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9185-9196.
    IgA vasculitis nephritis (IgAVN), as a common secondary glomerular disease in children and adolescents, seriously affects patients’ quality of life due to the increasing incidence, recurrent episodes, and other issues. Exploring safe and effective therapeutic strategies has become an important research direction in the current medical field. Traditional Chinese medicine possesses a multi-target regulatory advantage in the treatment of IgAVN, among which Leigongteng (Tripterygium wilfordii) and its active components exert definite curative effects in improving renal injury. Based on research progress at home and abroad, this paper systematically elaborates on the mechanisms of T. wilfordii in alleviating IgAVN-related renal injury, including inhibiting the inflammatory response, regulating immune imbalance, inducing abnormal cell apoptosis, and improving coagulation status. It further explores the regulatory networks and target of its related signaling pathways, so as to provide theoretical bases and research reference for the clinical application of T. wilfordii in the treatment of IgAVN-related renal injury.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9211-9223.
    Alzheimer’s disease (AD) is the most prevalent form of dementia among older adults. The primary clinical manifestations of this neurodegenerative disorder include behavioral disturbances, memory deficits, and impairments in cognitive function. The intricate pathophysiology of AD is thought to be associated with oxidative stress, inflammation, and gut microbiota imbalance. Modern pharmacological research shows that some natural small-molecule compounds have good preventive and therapeutic effects on AD due to their antioxidant, anti-inflammatory, neuroprotective, and other functions. As a result, these compounds have drawn more attention. This article reviews the mechanisms by which natural small-molecule compounds improve AD symptoms in vitro and in vivo under multi-target therapeutic strategies, and discusses the future development trends of these compounds as potential neuroprotective agents, providing references for basic application and clinical research.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9003-9014.
    Objective To investigate the protective effect and mechanism of Glycyrrhiza polysaccharide (GCP) on cisplatin-induced acute kidney injury (CI-AKI) in model rats and human tubular epithelial cell HK-2 injury model. Methods Control group, GCP high-dose (100 mg/kg) alone group, model group, GCP low-and high-dose (50, 100 mg/kg) groups were set up. A rat CI-AKI model was established via intraperitoneal injection (ip) of cisplatin. After GCP intervention, levels of creatinine (SCr), blood urea nitrogen (BUN), inflammatory factors in serum, and glutathione (GSH), malondialdehyde (MDA), ferrous ion (Fe2+) in renal tissue were measured; Hematoxylin-eosin staining (HE) and periodic acid-Schiff (PAS) staining were used to observe the pathological morphology of kidneys; TUNEL method was used to observe the apoptosis of renal tissue cells; Western blotting was used to measure expressions of kidney injury molecule-1 (KIM-1), neutrophil gelatinase associated lipocalin (NGAL), B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), cleaved cysteine aspartate protease-3 (cleaved Caspase-3), Kelch-like ECH-associated protein 1 (Keap1), nuclear factor E2 related factor 2 (Nrf2), nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (NQO1), heme oxygenase-1 (HO-1), glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), acyl-CoA synthase long-chain family member 4 (ACSL4), ferritin heavy chain 1 (FTH1) and ferritin light chain (FTL) protein in renal tissue. A renal tubular injury model was established by treating HK-2 cells with cisplatin. Control group, model group, GCP (800 μg/mL) group, and GCP + Nrf2 inhibitor ML385 (2 μmol/L) group were set up. Cell viability, reactive oxygen species (ROS), Fe2+ levels, Nrf2 nuclear translocation, and protein expressions of Bcl-2, Bax, Nrf2, NQO1, HO-1, GPX4, SLC7A11 and ACSL4 were measured to further clarify the exact effect of Nrf2 in GCP intervention in CI-AKI. Results GCP significantly reduced the levels of SCr and BUN in CI-AKI model rats (P < 0.001), alleviated cisplatin-induced renal pathological damage, restored renal tubular morphology, reduced the protein expressions of KIM-1 and NGAL (P < 0.01, 0.001), reduced the levels of inflammatory factors in serum of CI-AKI rats (P < 0.01, 0.001), inhibited the inflammatory response, up-regulated Bcl-2/Bax ratio (P < 0.05), down-regulated protein expression of cleaved Caspase-3 (P < 0.01, 0.001), alleviated apoptosis in renal tubular epithelial cells. GCP induced the dissociation of Keap1 and Nrf2 in vitro and in vivo, promoted Nrf2 nuclear translocation (P < 0.01), up-regulated the expressions of downstream proteins HO-1, NQO1, GPX4 and SLC7A11 (P < 0.05, 0.01, 0.001), increased GSH activity while down-regulated ACSL4 expression (P < 0.05, 0.01), reduced ROS, MDA and Fe2+ levels (P < 0.05, 0.01, 0.001), improved lipid peroxidation levels, reduced iron deposition, and inhibited ferroptosis in CI-AKI model rats, while ML385 could reverse the above protective effects (P < 0.05, 0.01, 0.001). Conclusion GCP could improve CI-AKI, and this protective effect may be achieved by activating the Nrf2 signaling pathway to inhibit ferroptosis in renal cells.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9224-9232.
    Skeletal muscle is one of the major organs for energy metabolism in the human body, and abnormalities in its lipid metabolism are closely linked to various metabolic diseases. Recent research has increasingly focused on the role of traditional Chinese medicine (TCM) in regulating skeletal muscle lipid metabolism. Both active TCM components and TCM compound prescriptions have shown promising potential in ameliorating skeletal muscle lipid metabolic disorders. Studies indicate that these TCM interventions restore skeletal muscle lipid homeostasis by modulating fatty acid oxidation, lipogenesis, and lipid droplet metabolism, which in turn improves systemic energy metabolism and ameliorates the pathologies of metabolic diseases. This review systematically summarizes the molecular mechanisms of TCM in regulating skeletal muscle lipid metabolism, providing a theoretical basis and drug development directions for the prevention and treatment of metabolic diseases, and promoting the application and development of TCM in the field of metabolic disease treatment.
  • Chinese Traditional and Herbal Drugs. 2025, 56(24): 9197-9210.
    As a traditional Chinese medicinal herb, Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus, CPPP) is valued for its clearing heat and removing toxin, resolving phlegm and dissipating mass effects. To date, more than 300 compounds, including phenanthrenes and bibenzyls, have been isolated from CPPP. With increasing research on its pharmacological activities—particularly antitumor and anti-inflammatory effects—the market demand for CPPP continues to rise. However, large-scale artificial cultivation of its authentic plant sources remains unresolved, and wild populations have sharply declined due to human disturbances, resulting in an increasingly prominent supply-demand imbalance. Artificial propagation is thus a key strategy to address the resource shortage. This review summarizes the current progress in artificial cultivation of CPPP focusing on both asexual propagation and sexual propagation, analyzes existing challenges and discusses future research priorities. Symbiotic seed germination of orchids, characterized by its short germination period, high efficiency, and enhanced seedling disease resistance, is regarded as a promising breakthrough for large-scale cultivation. Future studies should focus on the screening of germination-promoting fungi, the elucidation of symbiotic mechanisms, and the optimization of cultivation techniques, thereby supporting the conservation, sustainable utilization, and industrial development of CPPP.
  • YANG Mei, QIN Chong, YANG Min, PENG Shuming, LI Xiaoming, WU Ying, TIAN Li, TIAN Chunlian
    Chinese Traditional and Herbal Drugs. 2025, 56(24): 9145-9153.
    Objective To reveal the drought resistance physiological response mechanism of the raw material plant for vine tea of Nekemias grossedentata. Methods Taking annual N. grossedentata plants as subjects, a pot-controlled water experiment wasconducted with normal watering as the control to investigate the effects of light, moderate, and severe drought stress on photosynthetic characteristics, osmotic adjustment substances, and antioxidant enzyme activity in mature leaves. Results With the aggravation of drought, the leaf relative water content (RWC) initially increased and then decreased, as higher drought intensity led to increased water loss from the leaves. The photosynthetic parameters of each treatment decreased as the drought deepened. The net photosynthetic rate (Pn), stomatal conductance (Gs) and transpiration rate (Tr) decreased with the extension of drought time, but intercellular CO2 decreased first and then increased. In addition, the contents of chlorophyll a (Chla), chlorophyll b (Chlb) and carotenoids (Car) decreased slowly with the increase of drought. The contents of Leaf malondialdehyde (MDA) and osmotic adjustment substances in leaves increased with the severity of drought, accumulated and reached the peak at 14 d, then decreased with the duration of drought. The content of MDA induced by drought was the highest under severe drought (16.18 nmol/g). Compared with the control group, the proline (Pro) content in moderate and severe drought was significantly improved by 69.33% and 79.37% respectively. Under 14 d of drought, the content of soluble protein (SP) was relatively enhanced by 21.21%, 34.51% and 52.18% respectively, compared with the control. Antioxidant enzyme activities varied: The activity of superoxide dismutase (SOD) first boosted and then weakened with the continuous drought, and was eventually inactivated at 56 d. But, the peroxidase (POD) activity boosted significantly with the continuous and intensified drought, reaching 22.73, 23.06, 24.30, and 25.05 U/(g·min) at 56 d, respectively. Catalase (CAT) was active mid-stress but low early/late. Conclusion Under drought stress, N. grossedentata achieved water conservation by maintaining high leaf RWC and regulating Gs, Tr, and Pn.. It also accumulates MDA, Pro, and SP, and synergistically upregulates SOD, POD, and CAT activities to resist oxidative damage.
  • LIU Xuanyan, LIU Dingming, LONG Zhenting, LIU Zirui, LIU Wenlong, ZHANG Xili
    Chinese Traditional and Herbal Drugs. 2025, 56(24): 9063-9075.
    Objective To summarize and analyze the patterns and trends in the use of traditional Chinese medicine (TCM) for treating depression from ancient to modern times, providing a reference for the modern application of TCM in treating depression. Methods Software tools were employed to analyze data from the TCM big data analysis platform and the database of the National Intellectual Property Administration. Results The ancient classical prescription database included 115 effective prescriptions for treating depression, from which 35 high-frequency Chinese herbs were identified. The top nine herbs by frequency were Chaihu (Bupleurum chinense, 37 times, 4.16%), Baishao (Paeonia lactiflora, 36 times, 4.04%), etc. Their effects focused on soothing the liver, strengthening the spleen, and calming the mind. The properties and flavors were mainly cold-warm, sweet-bitter-pungent, and the meridians they acted on were primarily the heart, spleen, liver, and lung meridians. In the ancient prescriptions, the top five herb pairs by association were Chaihu-Baishao, Chaihu-Fuling (Poria), etc. The Chinese patent database included 207 effective prescriptions, from which 38 high-frequency Chinese herbs were identified. The top nine herbs by frequency were Chaihu (81 times, 4.56%), Suanzaoren (Ziziphus jujuba var. spinosa, 66 times, 3.71%), etc. Their efficacy classifications were mainly calming the mind, and promoting blood circulation and removing blood stasis. The properties and flavors were mainly cold-warm, sweet-pungent, and the meridians they acted on were primarily the heart, liver, kidney, spleen, and stomach meridians. In the modern prescriptions, the top five herb pairs by association were Chaihu-Suanzaoren, Danshen-BaJitian (Morinda officinalis), etc. Conclusion The medication of ancient anti-depressant prescriptions presents a “soothing the liver as the main focus, strengthening the spleen as a supplement, and nourishing blood” triangular structure. Modern TCM prescriptions inherit and innovate, combining herbs that soothe the liver and strengthen the spleen, and emphasize the compatibility of “promoting blood circulation and removing blood stasis, removing phlegm and opening orifices, and clearing heat and removing annoyance”. Modern anti-depressant TCM increases the application proportion of herbs that calm the mind, promote blood circulation, and clear heat, while continuing to use classical compatibility and developing new methods. The evolution of TCM anti-depressant compound prescriptions is the result of the deepening of pathogenesis theory, the promotion of modern pharmacological research, and the compulsion of clinical needs, forming a “multi-target modular compatibility” model, which can provide a reference for the development and application of anti-depressant TCM.
More
2026
2025